期刊文献+

人泌乳素腺瘤中ER、PTTG、bFGF的表达与肿瘤侵袭性的关系 被引量:1

Relationship between invasiveness and expression of ER、PGTT、bFGF in human prolactinomas
下载PDF
导出
摘要 目的探讨泌乳素腺瘤中雌激素受体(ER)、垂体瘤转化基因(PTTG)及碱性成纤维因子(bFGF)与肿瘤侵袭生长的关系。方法选择手术切除的泌乳素腺瘤标本46例,分为侵袭组和非侵袭组,采用免疫组化方法分别测定ER、PTTG和bFGF蛋白表达;从组织中提取RNA,经RT-PCR方法测定ER-mRNA和PTTG-mRNA。结果侵袭组ER、PTTG和bFGF蛋白表达的积分吸光度(IA)值分别为5385.1±1348.6、9874.2±2143.7和7938.5±1436.5,ER-mRNA和PTTG-mRNA吸光度比值分别为0.71和0.83,与非侵袭相比较差异显著(P<0.05)。结论ER、PTTG和bFGF与肿瘤的侵袭性密切相关,对肿瘤的发生,发展有重要作用。 Objective To explore the relationship between invasive growth and expression of ER, PTTG ,bFGF in human prolactinomas. Methods Fourty-six prolactinomas specimens were collected and divided into invasive group and non-invasive group. Expressions of ER, PTTG ,bFGF were examined by immunocytochemical method. Total RNA was extracted from specimens and ER-mRNA and PTTG-mRNA were detected by RT-PCR. Results IA of protein expression of ER, bFGF, PTTG in invasive prolactinomas was seperately 5385.1 ± 1348.6,9874.2 ± 2143.7,7938.5 ±1436.5; The optical density ratio of ER-mRNA and PTTG-mRNA was 0.71 and 0.83, difference between invasive group and non-vasive group was significant. Conclusions ER, PTTG, bFGF in human prolactinomas closely correlated with invasiveness of prolactinomas, and may play important function in prolactinomas.
出处 《基础医学与临床》 CSCD 北大核心 2006年第2期170-173,共4页 Basic and Clinical Medicine
关键词 泌乳素腺瘤 雌激素受体 垂体瘤转化基因 碱性成纤维因子 prolactinomas estrogen receptor pituitary tumor transforming gene basic fibroblast growth factor
  • 相关文献

参考文献12

二级参考文献20

  • 1胡波,贾永华,李小薇,王波,毛利民,吕申,应丽.碱性纤维母细胞生长因子(bFGF)的检测有助于判断肉瘤恶性程度[J].大连医科大学学报,2001,23(1):23-25. 被引量:4
  • 2郭海科,李绍珍,曹心,梁舜薇.人类晶体上皮细胞培养及其生长抑制的实验研究[J].中华眼科杂志,1995,31(2):102-104. 被引量:40
  • 3[1]Lewis S,Blevins,Denise K et al . Aggressive pituitary tumors. Oncology,1998,21(9): 1307
  • 4[2]Allyn Bregman. Laboratory investigations in cell & mol-ecular biology. Third Edition. Canada: John Wiley & Sons Inc. 1990. 116
  • 5[3]Hsu DW,Hakim F,Biller BMK et al . Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg,1993,78 753
  • 6[4]Murphy FY,Vesely DL,Jordan RM et al . Giant inva-sive prolactinomas. Am J Med,1987,83:995
  • 7[5]Kauppila A. Oestrogen and progestin receptors as prog-nostic indicators in endometrial cancer. Acta Oncologica,1989,28:561
  • 8[6]Stefaneanu L,Kovacs K,Horvath E et al . In situ hy-bridization study of estrogen receptor messenger ribonu-cleic acid in human adenohypophysial cells and pitui-tary adenomas. J Clin Endocrinol Metab,1994,78:83
  • 9[7]Kovacs L,Stefaneanu L,Horvath E et al . Prolactin-producing pituitary tumor:resistance to dopamine agonisttherapy. J Neurosurg,1995,82:886
  • 10Blask D E,Melatonin:Biosynthesis,Physiological Effects,and Clinical Applications,1993年,447页

共引文献42

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部